Reduction of the intake of food and water is responsible for reduction of litter growth when dams are treated with a progesterone antagonist.
Treatment of lactating rats with the anti-progestin Mifepristone or Onapristone adversely affects growth of their litters. The present studies aimed to elucidate the underlying mechanism. The treatment did not interfere with the behavioural interactions between mothers and pups, which are required for normal litter growth. Treatment with the antagonists had a stimulatory action on ovarian oestrogen production. However, ovarian hormones did not play a role in litter growth impairment, as this also occurred with lactating ovariectomized rats. Treatment with anti-progestins did not affect the concentrations of the macronutrients in milk (protein, lactose and lipid), nor did it change the fatty acid composition of lipid. Reduced litter growth was not related to a possible direct effect of exposure of the suckling young to the drugs via the milk. Direct injections into them unequivocally affected adrenal gland and testicular development, but did not affect their body-weight development. Milk secretion, as measured by the milk weight accumulating during 6 or 24 h following sudden removal of litters in advanced lactation, was not impaired by the treatments. However, the ingestion of food and water by dams treated with Mifepristone was significantly below that of control animals. It is concluded that litter growth impairment during treatment of lactating rats with anti-progestin results from the reduction of the intake of food and water by the mother.
Department of Endocrinology and Reproduction, Faculty of Medicine, Erasmus University, Rotterdam, The Netherlands.
P
P
van der Schoot
T A
TA
Zeegers
F A
FA
Muskiet
E J
EJ
Slappendel
D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development*; D001835:Body Weight / Q000187:drug effects; D004326:Drinking / Q000187:drug effects*; D004435:Eating / Q000187:drug effects*; D005260:Female; D006067:Gonanes / Q000494:pharmacology; D007774:Lactation / Q000187:drug effects; D008297:Male; D015735:Mifepristone / Q000494:pharmacology; D008892:Milk / Q000032:analysis; D010052:Ovariectomy; D011247:Pregnancy; D011374:Progesterone / Q000037:antagonists & inhibitors*; D051381:Rats; D011919:Rats, Inbred Strains
D006067:Gonanes; D015735:Mifepristone; D011374:Progesterone; C053238:onapristone